Earnings History Data for Ayala Pharmaceuticals (AYLA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Ayala Pharmaceuticals
Ayala Pharmaceuticals Inc. is a clinical-stage oncology company. It focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. Ayala Pharmaceuticals Inc. is based in Rehovot, Israel.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 04-11-2022 | PM | AYLA | Ayala Pharmaceuticals | 10.00 | -0.66 | -0.55 | 0.00 | Ayala Pharmaceuticals GAAP EPS of -$0.66 misses by $0.17, revenue of $0.09M misses by $0.51M [11/4/2022 9:21 AM] |
0.7141 | -0.03 (-4.08%) |
0.78 | 0.04 (4.85%) |
0.57 - 14.50 | 54,413 | 90,000 | 1,022 | ||
| 28-03-2022 | AH | AYLA | Ayala Pharmaceuticals | 60.00 | -0.66 | -0.67 | 0.00 | Ayala Pharmaceuticals GAAP EPS of -$2.80, revenue of $3.5M [3/28/2022 4:40 PM] |
4.06 | 0.09 (2.30%) |
0.0 | 0.0 (0.00%) |
3.31 - 14.95 | 37,355 | 20,000 | 0 | ||
| 15-11-2021 | PM | AYLA | Ayala Pharmaceuticals | 153.00 | -0.68 | -0.76 | 0.00 | Ayala Pharmaceuticals EPS beats by $0.12, misses on revenue [11/15/2021 8:43 AM] |
11.57 | 0.42 (3.77%) |
0.0 | 0.0 (0.00%) |
7.74 - 28.68 | 43,897 | 20,000 | 0 | ||
| 13-08-2021 | PM | AYLA | Ayala Pharmaceuticals, Inc. | 173.19 | -0.75 | -0.63 | -0.74 | Ayala Pharmaceuticals EPS misses by $0.12, misses on revenue [8/13/2021 8:49 AM] |
12.61 | -0.29 (-2.23%) |
0.0 | 0.0 (0.00%) |
7.74 - 28.68 | 3,041 | 50,000 | 0 | ||
| 14-05-2021 | PM | AYLA | Ayala Pharmaceuticals, Inc. | 132.00 | -0.74 | -0.71 | 0.00 | Ayala Pharmaceuticals EPS misses by $0.03, beats on revenue [5/14/2021 8:56 AM] |
10.00 | 0.20 (2.04%) |
0.0 | 0.0 (0.00%) |
8.62 - 28.68 | 25,272 | 10,000 | 0 | ||
| 25-03-2021 | PM | AYLA | Ayala Pharmaceuticals, Inc. | 166.00 | -0.73 | -0.58 | 0.00 | Ayala Pharmaceuticals EPS misses by $0.84, beats on revenue [3/25/2021 9:03 AM] |
12.11 | -0.06 (-0.53%) |
0.0 | 0.0 (0.00%) |
8.62 - 28.68 | 17,730 | 10,000 | 0 | ||
| 17-11-2020 | PM | AYLA | Ayala Pharmaceuticals, Inc. | 133.00 | -0.59 | -0.59 | 0.00 | Ayala Pharmaceuticals EPS misses by $0.03, beats on revenue [11/17/2020 8:14 AM] |
10.57 | -0.22 (-2.00%) |
0.0 | 0.0 (0.00%) |
8.62 - 16.50 | 5,872 | 5,502 | 0 | ||
|
|
||||||||||||||||||
| 17-11-2020 | PM | AYLA | Ayala Pharmaceuticals, Inc. | 137.89 | -0.59 | -0.59 | 0.00 | Ayala Pharmaceuticals EPS misses by $0.03, beats on revenue [11/17/2020 8:14 AM] |
10.31 | 0.03 (0.26%) |
0.0 | 0.0 (0.00%) |
8.62 - 16.50 | 894 | 5,592 | 0 | ||
|
|
||||||||||||||||||